About HASH

Founded: 2020
Employees: n/a
CEO: Jeffrey Swainson
WebsiteView website: www.simplysolventless.ca

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada. The company was incorporated in 2020 and is based in Calgary, Canada.

Recent HASH News & Updates

New Risk • Mar 03

New major risk - Market cap size

The company's market capitalization is less than US$10m. Market cap: CA$5.78m (US$4.23m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). High level of non-cash earnings (48% accrual ratio). Market cap is less than US$10m (CA$5.78m market cap, or US$4.23m).

Recent updates

No updates

Simply Solventless Concentrates Ltd. Stock Price

HASH Share Price Performance

HASH Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Simply Solventless Concentrates Ltd. Key Details

About HASH

Recent HASH News & Updates

New minor risk - Financial data availability

New major risk - Market cap size

Even With A 41% Surge, Cautious Investors Are Not Rewarding Simply Solventless Concentrates Ltd.'s (CVE:HASH) Performance Completely

Recent updates

Simply Solventless Concentrates Ltd. Competitors

Greenway Greenhouse Cannabis

Avicanna

InnoCan Pharma

Rapid Dose Therapeutics